These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 32514860)

  • 1. Synaptic Loss, ER Stress and Neuro-Inflammation Emerge Late in the Lateral Temporal Cortex and Associate with Progressive Tau Pathology in Alzheimer's Disease.
    Buchanan H; Mackay M; Palmer K; Tothová K; Katsur M; Platt B; Koss DJ
    Mol Neurobiol; 2020 Aug; 57(8):3258-3272. PubMed ID: 32514860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinctive temporal profiles of detergent-soluble and -insoluble tau and Aβ species in human Alzheimer's disease.
    Koss DJ; Dubini M; Buchanan H; Hull C; Platt B
    Brain Res; 2018 Nov; 1699():121-134. PubMed ID: 30102892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
    Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
    Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating small extracellular vesicles in Alzheimer's disease: a case-control study of neuro-inflammation and synaptic dysfunction.
    Singh R; Rai S; Bharti PS; Zehra S; Gorai PK; Modi GP; Rani N; Dev K; Inampudi KK; Y VV; Chatterjee P; Nikolajeff F; Kumar S
    BMC Med; 2024 Jun; 22(1):254. PubMed ID: 38902659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measures of cortical microstructure are linked to amyloid pathology in Alzheimer's disease.
    Spotorno N; Strandberg O; Vis G; Stomrud E; Nilsson M; Hansson O
    Brain; 2023 Apr; 146(4):1602-1614. PubMed ID: 36130332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer-like amyloid and tau alterations associated with cognitive deficit in temporal lobe epilepsy.
    Gourmaud S; Shou H; Irwin DJ; Sansalone K; Jacobs LM; Lucas TH; Marsh ED; Davis KA; Jensen FE; Talos DM
    Brain; 2020 Jan; 143(1):191-209. PubMed ID: 31834353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations Between Amyloid and Tau Pathology, and Connectome Alterations, in Alzheimer's Disease and Mild Cognitive Impairment.
    King-Robson J; Wilson H; Politis M;
    J Alzheimers Dis; 2021; 82(2):541-560. PubMed ID: 34057079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical characterization of Abeta and tau pathologies in mild cognitive impairment and Alzheimer's disease.
    Tremblay C; Pilote M; Phivilay A; Emond V; Bennett DA; Calon F
    J Alzheimers Dis; 2007 Dec; 12(4):377-90. PubMed ID: 18198424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of endoplasmic reticulum stress in amyloid β
    Goswami P; Afjal MA; Akhter J; Mangla A; Khan J; Parvez S; Raisuddin S
    Brain Res Bull; 2020 Dec; 165():108-117. PubMed ID: 33011197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression.
    Hales CM; Dammer EB; Deng Q; Duong DM; Gearing M; Troncoso JC; Thambisetty M; Lah JJ; Shulman JM; Levey AI; Seyfried NT
    Proteomics; 2016 Dec; 16(23):3042-3053. PubMed ID: 27718298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles.
    Sánchez-Juan P; Valeriano-Lorenzo E; Ruiz-González A; Pastor AB; Rodrigo Lara H; López-González F; Zea-Sevilla MA; Valentí M; Frades B; Ruiz P; Saiz L; Burgueño-García I; Calero M; Del Ser T; Rábano A
    Brain; 2024 May; 147(5):1667-1679. PubMed ID: 38634687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes.
    Kim DW; Tu KJ; Wei A; Lau AJ; Gonzalez-Gil A; Cao T; Braunstein K; Ling JP; Troncoso JC; Wong PC; Blackshaw S; Schnaar RL; Li T
    Mol Neurodegener; 2022 Dec; 17(1):83. PubMed ID: 36536457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between quantitative [
    Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
    Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The unfolded protein response is activated in the olfactory system in Alzheimer's disease.
    Murray HC; Dieriks BV; Swanson MEV; Anekal PV; Turner C; Faull RLM; Belluscio L; Koretsky A; Curtis MA
    Acta Neuropathol Commun; 2020 Jul; 8(1):109. PubMed ID: 32665027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant LATE-NC in Alzheimer's disease is not associated with increased tau or amyloid-β pathological burden.
    McAleese KE; Walker L; Erskine D; Johnson M; Koss D; Thomas AJ; Attems J
    Neuropathol Appl Neurobiol; 2020 Dec; 46(7):722-734. PubMed ID: 32896913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis identifies HSP90AA1, PTK2B, and ANXA2 in the human entorhinal cortex in Alzheimer's disease: Potential role in synaptic homeostasis and Aβ pathology through microglial and astroglial cells.
    Astillero-Lopez V; Villar-Conde S; Gonzalez-Rodriguez M; Flores-Cuadrado A; Ubeda-Banon I; Saiz-Sanchez D; Martinez-Marcos A
    Brain Pathol; 2024 Jul; 34(4):e13235. PubMed ID: 38247340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
    Attems J; Jellinger KA
    Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathological and Biomarker Findings in Parkinson's Disease and Alzheimer's Disease: From Protein Aggregates to Synaptic Dysfunction.
    Compta Y; Revesz T
    J Parkinsons Dis; 2021; 11(1):107-121. PubMed ID: 33325398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model.
    Hurtado DE; Molina-Porcel L; Iba M; Aboagye AK; Paul SM; Trojanowski JQ; Lee VM
    Am J Pathol; 2010 Oct; 177(4):1977-88. PubMed ID: 20802182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-localization of amyloid beta and tau pathology in Alzheimer's disease synaptosomes.
    Fein JA; Sokolow S; Miller CA; Vinters HV; Yang F; Cole GM; Gylys KH
    Am J Pathol; 2008 Jun; 172(6):1683-92. PubMed ID: 18467692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.